Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
11.45 EUR | +3.62% | +3.15% | -10.20% |
Mar. 14 | Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024 | CI |
Mar. 14 | Transcript : Hyloris Pharmaceuticals SA, 2023 Earnings Call, Mar 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.20% | 346M | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+0.74% | 209B | |
+2.95% | 212B | |
-6.05% | 205B | |
-3.61% | 157B |
- Stock
- Equities
- Stock Hyloris Pharmaceuticals SA - Euronext Bruxelles
- News Hyloris Pharmaceuticals SA
- Hyloris' Oral Mouth Rinse Shows Controlled Bleeding After Tooth Extraction in Early-stage Trial